03.01.02
Nutraceutix Enters
Canadian Market
Nutraceutix, Inc., Redmond, WA, has entered into a licensing agreement with Canada-based Nutravite to package, market and distribute Nutraceutix’s Controlled Delivery Technology (CDT)-glucosamine and CDT-glucosamine/chondroitin products in the Canadian marketplace. The agreement extends Nutraceutix’s patented CDT glucosamine products to the Canadian market with the assistance of Nutravite, which plans to offer unique once-daily dosage glucosamine products and technologies under the Nutravite label to the Canadian health food market, retail pharmacies and mass merchandisers.
On the Asian front, through its strategic partner Sinphar Pharmaceutical Company, Taipei, Taiwan, Nutraceutix introduced its Controlled Delivery Technology at the 2nd Taipei International Biotech Fair in December.
Canadian Market
Nutraceutix, Inc., Redmond, WA, has entered into a licensing agreement with Canada-based Nutravite to package, market and distribute Nutraceutix’s Controlled Delivery Technology (CDT)-glucosamine and CDT-glucosamine/chondroitin products in the Canadian marketplace. The agreement extends Nutraceutix’s patented CDT glucosamine products to the Canadian market with the assistance of Nutravite, which plans to offer unique once-daily dosage glucosamine products and technologies under the Nutravite label to the Canadian health food market, retail pharmacies and mass merchandisers.
On the Asian front, through its strategic partner Sinphar Pharmaceutical Company, Taipei, Taiwan, Nutraceutix introduced its Controlled Delivery Technology at the 2nd Taipei International Biotech Fair in December.
